Catherine Cusack Purchases Shares in Sabra Health Care REIT
Insider Catherine Cusack buys 8,310 shares of Sabra Health Care REIT.
Key Points
- Catherine Cusack acquired 8,310 shares of Sabra Health Care REIT on June 17, 2026.
- Sabra Health Care REIT trades at $18.12 with a market cap of $4.57 billion and a P/E ratio of 28.76.
- Analysts have set a mean price target of $22.54, with Wells Fargo maintaining a 'buy' rating.
Catherine Cusack, an insider at Sabra Health Care REIT, Inc. (NasdaqGS: SBRA), purchased 8,310 shares of the company on June 17, 2026. The transaction adds to a series of insider purchases made on the same day. Sabra's stock was trading at $18.12 at the time of the purchase.
Insider Buying and Selling at Sabra Health Care REIT, Inc.
On June 17, 2026, several insiders at Sabra Health Care REIT, including Catherine Cusack, acquired 8,310 shares each. These transactions were not made under a pre-planned trading program. Other insiders involved in the purchases include Kono Ann, Lynne Katzmann, Michael Foster, Jeffrey Malehorn, and Craig Barbarosh.
Other Institutional Activity in Sabra Health Care REIT
Several institutional investors have also been active in Sabra Health Care REIT. BlackRock, Inc. increased its holdings by 704,770 shares, bringing its total to 39,098,389 shares valued at approximately $751.86 million. Principal Financial Group Inc. added 98,770 shares, resulting in a total of 25,052,121 shares worth about $481.75 million. State Street Corp grew its position by 198,311 shares, ending with 12,099,951 shares valued at $232.68 million. Meanwhile, JPMorgan Chase & Co. significantly boosted its holdings by 5,569,621 shares, totaling 8,201,220 shares with a value of $159.43 million.
Sabra Health Care REIT Stock Snapshot
Shares of Sabra Health Care REIT (NasdaqGS: SBRA) are trading near $18.12. The company has a market capitalization of approximately $4.57 billion and a P/E ratio of 28.76. The stock's 52-week range is between $17.17 and $21.28. Sabra's 50-day moving average is $19.94, and its 200-day moving average is $19.31. The real estate investment trust has a beta of 0.626, indicating lower volatility compared to the broader market.
Recent Earnings
Sabra Health Care REIT reported revenue of $815.66 million, reflecting a growth rate of 21.7%. The company achieved a net margin of 19.15% and a return on equity of 5.68%. Earnings per share stood at $0.63. Sabra is expected to release its next earnings report on August 3, 2026.
Analysts Set New Price Targets
On June 18, 2026, Scotiabank maintained its 'hold' rating on Sabra Health Care REIT with a price target of $19. Wells Fargo, on June 1, 2026, reaffirmed its 'buy' rating, setting a target price of $23. The consensus among analysts is a 'buy' recommendation, with a mean price target of $22.54 based on 13 analyst opinions.
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. is a real estate investment trust specializing in healthcare facilities across the United States and Canada. The company, headquartered in Tustin, California, is led by CEO Richard K. Matros and employs about 58 people. Sabra focuses on owning and investing in properties that serve the healthcare sector, operating as a self-administered and self-managed REIT.
Bottom Line
Catherine Cusack's recent purchase of Sabra Health Care REIT shares highlights ongoing insider confidence in the company. Investors often track insider transactions as a potential indicator of a company's prospects. It's essential to remember that insider transactions are backward-looking and may not reflect current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.